Allopurinol Combination Study
Public ClinicalTrials.gov record NCT01001338. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Study identification
- NCT ID
- NCT01001338
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ardea Biosciences, Inc.
- Industry
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Interventions
- RDEA594 Drug
- Placebo Drug
- Allopurinol Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Dec 31, 2010
- Completion
- Jul 31, 2016
- Last update posted
- Jan 23, 2017
2009 – 2016
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85050 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Los Angeles | California | 90017 | — |
| Not listed | Stanford | California | 94305 | — |
| Not listed | Boca Raton | Florida | 33432 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Fort Lauderdale | Florida | 33334 | — |
| Not listed | Jupiter | Florida | 33458 | — |
| Not listed | Meridan | Idaho | 83642 | — |
| Not listed | Lexington | Kentucky | 40504 | — |
| Not listed | Wheaton | Maryland | 20902 | — |
| Not listed | Las Vegas | Nevada | 89183 | — |
| Not listed | Reno | Nevada | 89502 | — |
| Not listed | Harrisburg | North Carolina | 28075 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Cleveland | Ohio | 44122 | — |
| Not listed | Mayfield Village | Ohio | 44143 | — |
| Not listed | Durham | South Carolina | 27710 | — |
| Not listed | Rock Hill | South Carolina | 29732 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Jackson | Tennessee | 38305 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | San Antonio | Texas | 78221 | — |
| Not listed | West Jordan | Utah | 84088 | — |
| Not listed | Chesapeake | Virginia | 23320 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01001338, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01001338 live on ClinicalTrials.gov.